Literature DB >> 8126460

Prediction of a putative fusion peptide in the S protein of hepatitis B virus.

I Rodríguez-Crespo1, J Gómez-Gutiérrez, M Nieto, D L Peterson, F Gavilanes.   

Abstract

Sequence analysis of the S protein of hepatitis B virus (HBV) reveals a stretch of 23 hydrophobic amino acids in the amino-terminal region which shows a high degree of similarity with known fusogenic peptides from other viruses. Additionally, this sequence also appears to be highly conserved within the hepadnavirus family. Taken together, the different criteria used in this work suggest fusogenic activity in the amino-terminal region of the S protein of the envelope of HBV.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8126460     DOI： 10.1099/0022-1317-75-3-637

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  7 in total

1.  Entry of duck hepatitis B virus into primary duck liver and kidney cells after discovery of a fusogenic region within the large surface protein.

Authors:  Claudia Maenz; Shau-Feng Chang; Alicja Iwanski; Michael Bruns
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

2.  Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.

Authors:  Matthieu Blanchet; Camille Sureau
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

3.  The induction of respiratory syncytial virus-specific cytotoxic T-cell responses following immunization with a synthetic peptide containing a fusion peptide linked to a cytotoxic T lymphocyte epitope.

Authors:  S C Hsu; D M Shaw; M W Steward
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

4.  The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity.

Authors:  Charlotte Lepère-Douard; Maud Trotard; Jacques Le Seyec; Philippe Gripon
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

Review 5.  Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule.

Authors:  Qiushi Liu; Masaharu Somiya; Shun'ichi Kuroda
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

Review 6.  Current Progress of Virus-mimicking Nanocarriers for Drug Delivery.

Authors:  Masaharu Somiya; Qiushi Liu; Shun'ichi Kuroda
Journal:  Nanotheranostics       Date:  2017-10-31

Review 7.  Hepatitis B Virus Entry into Cells.

Authors:  Charline Herrscher; Philippe Roingeard; Emmanuelle Blanchard
Journal:  Cells       Date:  2020-06-18       Impact factor: 6.600
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.